Questions a plan sponsor actually asks.
What is Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate used for?
Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate is a this drug class medication tracked in Medicare Part D.
Is there a generic for Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate?
Yes. 4 ANDAs filed at FDA, 2 generic manufacturers currently shipping.
How much does my plan pay for Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate?
Across 329 Part D plans, Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate averages $2.34/unit (NADAC). Lowest available: $1.43/unit. Highest in distribution: $3.24/unit.
Is Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate on the FDA shortage list?
No. Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.